A signing ceremony for the Regional Cell Preparation Center (Tissue Bank) and Application Project was held in Ordos High-Tech Zone on Jan 5. This project aims to establish a full-chain industry system in the field of cell therapy. It will supply standardized cell products to local and surrounding medical institutions, enhancing healthcare services for the community.

With a total investment of 103 million yuan ($1.74 million), the project focuses on the research and industrial application of stem cell and immune cell technologies. It includes the construction of the Regional Cell Preparation Center (Tissue Bank), a life sciences education base, and a precision medicine health management center. The project is expected to commence operations in October 2026.

The Ordos High-Tech Zone is actively implementing the national biotechnology development strategy, leveraging its advantageous location, comprehensive facilities, and first-class business environment to explore new frontiers in the biopharmaceutical industry and cultivate a robust ecosystem for this sector.

The zone is committed to fully implementing national and local policies supporting the biopharmaceutical industry, ensuring the provision of essential resources for projects and a secure, supportive environment for businesses to invest, innovate, and grow.